Nuclear WarfareRadiation DosageDose-Response Relationship, RadiationRadiation InjuriesRadiation, IonizingRadiation EffectsNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalRadiation ToleranceGamma RaysRadiation-Sensitizing AgentsRadiation GeneticsNuclear WeaponsRadiotherapyRadiation-Protective AgentsRadiationBystander EffectAntineoplastic AgentsRadiation ProtectionRadiation MonitoringX-RaysSurvivalJapanRadiation OncologyTime FactorsCell Line, TumorCosmic RadiationDrug Screening Assays, AntitumorNeoplasmsRadiation PneumonitisBackground RadiationApoptosisDoxorubicinUltraviolet RaysRadiometryRadiotherapy DosageCell SurvivalCombined Modality TherapyDNA DamageDrug Resistance, NeoplasmCisplatinAntineoplastic Agents, PhytogenicAntibiotics, AntineoplasticAcute Radiation SyndromeTumor Cells, CulturedDrug Delivery SystemsMice, NudeXenograft Model Antitumor AssaysRadioactive Hazard ReleaseCobalt RadioisotopesRadiobiologyRadiotherapy, ConformalDrug CarriersRadiation Hybrid MappingCell ProliferationDose FractionationDNA RepairEllipticinesBreast NeoplasmsRadiotherapy, Intensity-ModulatedEtoposideBrachytherapyPaclitaxelCell CycleLinear Energy TransferRadiodermatitisDose-Response Relationship, DrugCamptothecinRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantInhibitory Concentration 50Drug Resistance, MultipleBrain NeoplasmsLeukemia, Radiation-InducedP-GlycoproteinMolecular StructureBody BurdenSynchrotronsRadiation, NonionizingTumor Suppressor Protein p53FluorouracilRelative Biological EffectivenessElectromagnetic RadiationDrug SynergismTreatment OutcomeDrug DesignParticle AcceleratorsCesium RadioisotopesAntineoplastic Combined Chemotherapy ProtocolsFluoroscopyAbnormalities, Radiation-InducedEnzyme InhibitorsHead and Neck NeoplasmsGene Expression Regulation, NeoplasticDNAWhole-Body IrradiationSunlightThermoluminescent DosimetryProdrugsDNA Topoisomerases, Type II